Skip to main content
. 2021 Mar 25;21:135. doi: 10.1186/s12876-021-01720-w

Table 2.

Prevalence of NAFLD and NASH with significant fibrosis in Thailand in 2019

Age group Thai population size NAFLD prevalence (%) NAFLD cohort NASH with significant fibrosis prevalence (%) NASH with significant fibrosis cohort
18–39 20,533,776 35.12 7,212,381 7.14 1,466,099
40–59 19,919,412 34.49 6,869,359 5.80 1,155,851
60 +  11,136,059 22.57 2,513,210 3.05 339,981
Total 51,589,247 32.17 16,594,951 5.74 2,961,931

NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis